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ABSTRACT 
The   Non aqueous titration   method was developed for quantitave analysis of  L-  Carnitine L-Tartarate    in  multivitamin  tablets. The   Non 
aqueous titration method was carried out using 0.1  N  Perchloric acids. The   present   analytical    method   was validated according to ICH 
guidelines  (ICH,Q2(R1)).  The   calibration   curve   was  found    to   linear  with correlation coefficient   (r 2=0.99995),  Bias   (-0.35)  in  the  
range  of  50  to 150  %  of  standard solution. The   precision   and   recovery   were determined   and  all  the  parameter value found within 
acceptance  limit. The  value  for  both method  and intermediate  precision were found to 0.57 % and recovery  found  to 99.11 to 99.59 %.  The   
validation parameter  study  was  method  precision,  intermediate   precision,   Linearity   and   recovery.  This is a   convenient, precise   and   
rapid    accurate  method    for  the estimation  of   L-Carnitine  L-Tartarate  in  Bulk  and Pharmaceutical dosage forms (Multivitamin Tablets). 
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INTRODUCTION 
In  the  literature  survey  it is observed  that there are few 
analytical  methods reported for the estimitation of  L-
Carnitine L- Tartarate in pharmaceutical tablet formulation. 
L-Carnitine is  an essential drug commercially available as in  
tartaric acid form and chemically described as Bis [(2R)-3-
carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium] 
(2R,3R)-2,3-dihydroxysuccinate . L-Carnitine L-Tartarate  is 
a white  crystalline powder with a Molecular weight 472.49 
,Molecular formula  C18H36N2O12  and   highly soluble in 
Water.L-Carnitine an amino acids that is naturally produce 
in the body which is important for Heart,Brain function and 
Muscle movement.Due to too low of L-Carnitine  disease may 
be Chest Pain,High Chlosterol,Brain development 
disorder,Diabetes and AIDS etc.The biologically active form 
of L-carnitine is a carrier molecule that transports activated 
long chain fatty acids from the cytosol to mitochondria 
where fatty acids are oxidized resulting in ATP 
production.The typical dose of L-Carnitine is in between  1  
to 3 grams per day.This testing method is suitable when L-
Carnitine L-Tartarate  is in combination with Mecobalamin 
and folic Acid  in tablets dosase form.Literature survey 
reveals that Non-aqueous titration methods used for 
quantitative estimation of  L-Carnitine L-Tartarate is very 
Simple, accurate and  low costing analysis.In the proposed 
methods optimization and validation are reported. 
 
Fig. -1: Chemical structure of L-Carnitine L-Tartarate 
MATERIAL AND METHODS 
Reagents and Chemical: Reference standard of L-Carnitine 
L-Tartarate were used for spiking in recovery study. Glacial 
Acetic Acid, Crystal Violet Indicator and 0.1M Perchloric 
acid of A.R grade were used. The combined tablet 
formulation purchased from local market. 
Quantitative determination of L-Carnitine L-Tartarate: 
Crush 10 tablets  and weigh crush powder   equivalent  to  
750 mg  of  L-Carnitine-L-tartrate  of  label claim mentioned 
on carton or strip of tablets into 250 ml volumetric  
flask,dissolve it into 60 ml of glacial acetic acid, add 2-3 
drops of crystal violet indicator and titrate with 0.1M 
Perchloric Acid to  green  end  point.   Blank   determination   
was performed out  for  necessary  correction. 
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1ml of 0.1 M Perchloric Acid consumed is equivalent to 
0.047249 g of L-Carnitine L- Tartarate. 
Calculation           
L-Carnitine L- Tartarate (mg/tab)  (A)   =   
                                 
           
   
                      
           
      
 
Where, 
            N          =  Normality of Perchloric acid 
           V1         =  Consumed volume due to sample 
           V2         =  Consumed volume due to Blank 
           W          =  weight of the Sample in mg 
           AW       =  Average Weight of  tablets 
           47.249   =  Factor due to  L-Carnitine L- Tartarate 
           32.24     =  Factor due to L-Carnitine  
VALIDATION PARAMETER: 
 Precision: The Method precision  and Intermediate 
precision were studies by six different preperation of Test 
sample and its acceptance crieteria for  % RSD of result 
should not more than 2.0%.The % RSD was determined  by 
using the following equation. 
 
Where,  SD = Standard deviation       X   = Airthmatic Mean 
Linearity :The Linearity was obtained using  five different 
concentration of L-Carnitine L-tartarate  standard  solution 
50%,80%,100%,120% and 150% .The consumed volume of  
each standard solution and standard weight were recorded. 
The Value  for correlation  coefficient,Slope, Intercept and 
Bias  was calculated. 
Accuracy : To perform accuracy ,recovery studies was 
carried out by adding standard weight to sample solution 
(Previously neutralized Sample solution) by  three  different 
concentration 50%,100% ,150% and each triplicate 
preperation. The Percentage recovery is calculated by the 
following equation. 
 Percentage recovery =    Titre Value x 100 
                                                  True Titre Value 
RESULT AND DISCUSSION  
After obtaining data evaluating their statistical parameters 
which include Linearity,precision and Accuracy .The % RSD 
of result found  for Method precision is 0.570 %  and for 
Intermediate precision (Ruggedness)  is also 0.570 % , which 
represents good precision of testing method. The results are 
listed in Table 1 , Table 2 and Table 5. 
Table 1:  Method Precision 
Sr.No Weight Taken Normality Burette Reading            Results(in %) 
01 752.35 0.0996 24.2 98.98 
02 751.16 0.0996 24.1 98.73 
03 753.68 0.0996 24.3 99.21 
04 748.95 0.0996 24.1 99.02 
05 749.25 0.0996 24.4 100.21 
06 755.35 0.0996 24.5 99.81 
 
Mean 99.33 
Standard Deviation 0.566 
RSD (Limit:Not more than 2.0%) 0.570 
 
Table 2:  Ruggedness (Intermediate Precision) 
Sr.No Weight Taken Normality Burette Reading            Results (in %) 
01 751.69 0.0996 24.3 99.48 
02 748.95 0.0996 24.2 99.43 
03 755.69 0.0996 24.1 98.14 
04 749.68 0.0996 24.3 99.74 
05 748.36 0.0996 24.1 99.10 
06 749.65 0.0996 24.2 99.34 
 
Mean 99.20 
Standard Deviation 0.563 
RSD (Limit:Not more than 2.0%) 0.570 
 
LINEARITY : The Value  for  Correlation coefficient (0.99995) and  Bias (-0.35) are found good closeness to Acceptance limit  
mentioned  in Table 3. 
Table  3 : Linearity  Related Acceptance Value 
Sr.No Concentration Burette Reading(Consumed Volume) 
01 250.32 mg (50%) 12.1 
02 402.15 mg (80%) 19.2 
03 501.25 mg (100%) 24.1 
04 601.3 mg (120%) 28.9 
05 750.32 mg (150%) 36.2 
Regression 
Values 
Correlation(Limit :Not less than 0.9999)       0.99995 
Slope 0.05 
Intercept -0.09 
Bias  (Limit: ±3 ) -0.35 
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Figure 2 :  Linearity Curve Between Concentration and Consumed  Volume 
ACCURACY  : Accuracy was determined  by  three  different concentration (50%,100% and 150%) and each triplicate 
preperation.The percentage  recovery was  found  from 99.11% to 99.59 % listed in Table 4,which confirms  the Accuracy of 
proposed method. 
Table 4:  Recovery and Accuracy 
Spike Weight Taken %Assay      Results (in %) 
50%     -01 375.56 99.14 Mean  : 99.17  % 
RSD     : 0.64  % 
 
50%    -02 376.15 99.81 
50%    -03 374.69 98.55 
100%  -01 751.26 99.53 Mean  : 99.59  % 
RSD     : 0.33  % 
 
100%  -02 751.29 99.94 
100%  -03 746.85 99.3 
150%  -01 1125.68 98.96 Mean  : 99.11 % 
RSD     : 0.14    %  
 
150% -02 1126.58 99.15 
150% -03 1128.95 99.22 
                                                                                    RSD Limit:Not more than 2.0% 
             
Table - 5:  Summary of all Results 
       Validation parameter    Results 
      Linearity 
     (a) Correlation Coefficient          0.99995 
     (b) Bias         -0.35 
     Precision 
     (a) Method Precision           0.57% 
     (b) Intermediate Precision           0.57% 
     Accuracy 
     (a) 50 %         99.17 % 
     (b) 100%         99.59% 
     (c) 150%         99.11% 
 
Roghaieh Khoshkam and Minoo Afshar develop RP HPLC 
method for determination of L-Carnitine L- Tartarate which 
is high cost analysis in comparison to Titration method. 
However the reported Non aqueous titration method of L-
Carnitine L- Tartarate is low cost analysis completed in short 
duration.This methods can be used for routine analysis of L-
Carnitine L- Tartarate in multivitamin tablet. 
 CONCLUSION 
The proposed non-aqueous titration method was found to 
precise, accurate, rugged, Linearise and results are 
accordance with ICH Guidelines. Hence this method can 
easily and conveniently adopt for routine analysis of L-
Carnitine L- Tartarate in pharmaceutical dosage forms.    
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